CoChat

The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.

Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies

Open access
Chan, D.S.M., Vieira, A.R., Aune, D., Bandera, E.V., Greenwood, D.C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., Norat, T. · 2014 · Annals of Oncology

Abstract

BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.

Checked 2026-10-11 · 1 reference not checked yet

Overview

CoChat Summary

## TL;DR

This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.

## Key findings

  • Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
  • For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
  • before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
  • <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
  • ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
  • For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
  • before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
  • <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
  • ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
  • Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
  • Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
  • Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
  • The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.

## Methods

  • Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
  • Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
  • Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.

## Limitations

  • The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
  • It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
  • The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/annonc/mdu042

Cites

125 of 126 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Flowchart of search.
Figure 1. Flowchart of search.CC BY-NC · PubMed Central
Figure 2. Categorical meta-analysis of pre-diagnosis BMI and total mortality.
Figure 2. Categorical meta-analysis of pre-diagnosis BMI and total mortality.CC BY-NC · PubMed Central
Figure 3. Non-linear dose–response curves of BMI and mortality.
Figure 3. Non-linear dose–response curves of BMI and mortality.CC BY-NC · PubMed Central
Figure 4. Linear dose–response meta-analysis of BMI and total mortality.
Figure 4. Linear dose–response meta-analysis of BMI and total mortality.CC BY-NC · PubMed Central
Figure 5. Categorical meta-analysis of pre-diagnosis BMI and breast cancer mortality.
Figure 5. Categorical meta-analysis of pre-diagnosis BMI and breast cancer mortality.CC BY-NC · PubMed Central
Figure 6. Linear dose–response meta-analysis of BMI and breast cancer mortality.
Figure 6. Linear dose–response meta-analysis of BMI and breast cancer mortality.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations

47 more claims

Create a free account to see all 76 claims and to verify the 9 references still open.

See all claims — free account
  • The quote only partly states this claim. 4
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Citations

Cites

Show all 126 references

Research works printed but not linked: 2

  1. Tobias, 1999, Assessing the influence of a single study in meta-analysis, Stata Tech Bull, 47, 15
  2. Donegan, 1978, The prognostic implications of obesity for the surgical cure of breast cancer, Breast, 4, 14

Cited by

See all 1,165

Metadata

Authors
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
Affiliations
  • Imperial College London (GB)
  • Norwegian University of Science and Technology (NO)
  • Rutgers, The State University of New Jersey (US)
  • University of Leeds (GB)
  • Fred Hutch Cancer Center (US)
  • Oslo University Hospital (NO)
  • Newcastle University (GB)
Corresponding author
Chan, D.S.M.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2014-10
Volume
25
Issue
10
Pages
1901-1914
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2149466392
Cited by
1,165
References
123
Citations by year
2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
FWCI
9.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Oncology (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • World Cancer Research Fund International (2007/SP01)
  • World Cancer Research Fund International/American Institute for Cancer Research
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
MeSH terms
Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies. https://app.cochat.ai/papers/10.1093/annonc/mdu042
The paper
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014). Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies. Annals of Oncology. https://doi.org/10.1093/annonc/mdu042

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.